Ledger.Open graph →
SEC Form D · filed March 31, 2021

OncoResponse Inc

Offering
$60.0M
Sold
$40.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Kamal D. Puri · Seattle, WAExecWende M. Hutton · Menlo Park, CADirectorSteven A. Gillis · Chicago, ILDirectorClifford J. Stocks · Seattle, WAExec · DirectorJohn A. Mckearn · St. Louis, MODirectorRoberto A. Deponti · None, LuxembourgDirectorTed A. Koutouzis · Evanston, ILDirectorBob J. Lechleider · Seattle, WAExecWesley P. Kubesch · Houston, TXDirectorBen Gerenstein · Chantilly, VAExecRichard H. Coles · Grand Cayman, Cayman IslandsExec · DirectorRobert A. Contreras · CHICAGO, ILDirectorThomas W. Brown · Beverly, MADirectorJoel A. Hirsh · CHICAGO, ILDirectorTheodore A. Rupp · CHICAGO, ILDirectorPatrick J. Hojlo · Doha, S3DirectorDaguang J. Wang · Cambridge, MADirectorDivesh C. Makan · San Francisco, CADirectorBrent K. Rentmeester · Stoneham, MAExec · DirectorJ. P. Nelli, Jr · South Jordan, UTDirectorBryan B. Hinton · South Jordan, UTDirectorDawn V. Smith · South Jordan, UTDirectorMatt Bailey · Durham, NCDirectorRobert M. Eversole · Columbus, OHExecPatrick J. Hojlo · Doha, S3DirectorDaguang J. Wang · Cambridge, MADirectorBob J. Lechleider · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗